Pyrrolidinyl and piperidinyl ketone derivatives and uses...

Details Pyrrolidinyl and piperidinyl ketone derivatives and uses... Pyrrolidinyl and piperidinyl ketone derivatives and uses...

2007-12-18

2011-12-27

Havlin, Robert (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

08084623

ABSTRACT:
Compounds of the formula:or pharmaceutically acceptable salts thereof,wherein m, n, Ar, R1, R2, Raand Rbare defined herein. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the compounds.

REFERENCES:
patent: 2248018 (1941-07-01), Otto
patent: 4341698 (1982-07-01), Carr et al.
patent: 4443451 (1984-04-01), Kennis et al.
patent: 7115750 (2006-10-01), Kato et al.
patent: 2002/0151712 (2002-10-01), Lin et al.
patent: 2004/0034019 (2004-02-01), Tomlinson et al.
patent: 2005/0090504 (2005-04-01), Gong et al.
patent: 2006/0167044 (2006-07-01), Arnaiz et al.
patent: 30 39 974 (1981-05-01), None
patent: 0 161 874 (1989-09-01), None
patent: 2 468 592 (1981-05-01), None
patent: 931789 (1961-03-01), None
patent: 2 061 0937 (1981-05-01), None
patent: WO 91/09594 (1991-07-01), None
patent: WO 96/26196 (1996-08-01), None
patent: WO 96/26196 (1996-08-01), None
patent: WO 96/41802 (1996-12-01), None
patent: WO 97/19073 (1997-05-01), None
patent: WO 98/31669 (1998-07-01), None
patent: WO 01/14331 (2001-03-01), None
patent: WO 01/14331 (2001-03-01), None
patent: WO 02/22572 (2002-03-01), None
patent: WO 02/22572 (2002-03-01), None
patent: 02072548 (2002-09-01), None
patent: WO 03/017927 (2003-03-01), None
patent: WO 03/017927 (2003-03-01), None
patent: 03068221 (2003-08-01), None
patent: WO 03/088908 (2003-10-01), None
patent: WO 03/088908 (2003-10-01), None
patent: 2004022712 (2004-03-01), None
patent: WO 2004/024720 (2004-03-01), None
patent: WO 2004/033427 (2004-04-01), None
patent: WO 2004/080925 (2004-09-01), None
patent: WO 2004/080925 (2004-09-01), None
patent: WO 2005/047250 (2005-05-01), None
patent: WO 2005/047253 (2005-05-01), None
patent: WO 2005/082904 (2005-09-01), None
patent: 2005123716 (2005-12-01), None
patent: WO 2006/003147 (2006-01-01), None
patent: WO 2006/016912 (2006-02-01), None
patent: WO 2006/016912 (2006-02-01), None
patent: WO 2006/034341 (2006-03-01), None
patent: WO 2006/034341 (2006-03-01), None
patent: WO 2006/066989 (2006-06-01), None
patent: 2006081332 (2006-08-01), None
patent: WO 2006/086609 (2006-08-01), None
patent: WO 2006/086609 (2006-08-01), None
patent: 2007068619 (2007-06-01), None
patent: 2007117401 (2007-10-01), None
Kubinyi (3D QSAR in Drug Design: Ligand-Protein Interactions and Molecular Similarity, vol. 2-3, Springer, 1998, 800 pages), TOC and pp. 243-244 provided.
Rhoden et al. (J. Bioorg. Med. Chem. 13 (2005) 5623-34).
Bergel et al. (CAPLUS abstract of GB 584877).
Beer, B., et. al. “DOV 216,303, a “Triple” Reuptake Inhibitor: Safety, Tolerability, and Pharmacokinetic Profile,”J. Clinical Pharmacology(2004) vol. 44, pp. 1360-1367.
Isaacson, J., et. al. “Expeditious Access to Unprotected Racemic Pyroglutamic Acids,”J. Org. Chem. (2007) vol. 72, pp. 3913-3916.
Ong, H.H., et. al. “Novel Tetracyclic Spiropiperidines. II. Synthesis of 2-Aryl-2,3-dihydrospiro[benzofuran-3,4′-piperidines] (1,2),”J. Heterocyclic Chem. (1981) vol. 18, pp. 815-820.
Rhoden, J.B., et. al. “Structure-activity studies of 3′-4′ dichloro-meperidine analogues at dopamine and serotonin transporters,”Bioorganic&Medicinal Chem. (2005) vol. 13, pp. 5623-5634.
Skolnick, P., et. al. “Antidepressant-like Actions of DOV 21,947: a “triple” Reuptake Inhibitors,”European J. Pharmacology(2003) vol. 461, pp. 99-104.
Wagner, P.J., et. al. “Absence of Intramolecular Charge-Transfer Quenching in Photoexcited 4-Benzoylpiperidines,”J. Am. Chem. Soc. (1977) vol. 99, pp. 1858-1863.
Burkholder, T.P., et. al. “Synthesis and Structure-Activity Relationships for a Series of Substituted Pyrrolidine NK1/NK2Receptor Antagonists,”Bioorganic&Medicinal Chemistry Letters(1997) vol. 7 (19), pp. 2531-2536.
Gakis, N., et. al. “Zur Photodimerisierung von 3-Phenyl-2H-azirinen),”Helvetica Chimica Acta(1972) vol. 55, pp. 748-752.
Ikeda, M. et. al. “A Formal Total Synthesis of (−−)-Cephalotaxine,”Chem. Pharm. Bull. (1999) vol. 47 (7), pp. 983-987.
Nakanishi, M., et. al., “Studies of Piperidine Derivatives. 1,”Journal of Medicinal Chemistry(1970) vol. 13 (4), pp. 644-648.
Nishi, T., et. al., “Combined NK,1and NK2Tachykinin Receptor Antagonists: Synthesis and Structure-Activity Relationships of Novel Oxazolidine Analogues,”Bioorg. &Medicinal Chem. Lett. (1999) vol. 9, pp. 875-880.
Scopes, D. I. C., et. al. “New κ-Receptor Agonists Based upon a 2-[(Alkylamino)methyl]piperidine Nucleus,”J. Med. Chem. (1992) vol. 35, pp. 490-501.
Seebach, D., et. al. “Alkylation of Amino Acids without Loss of the Optical Activity: Preparation of α-Substituted Proline Detrivatives. A Case of Self-Reproduction of Chirality,”J. Am. Chem. Soc. (1983) vol. 105, pp. 5390-5398.
Wantanabe, Y., et. al. “Synthesis and 5-HT2Antagonist Activity of Bicyclic 1,2,4-Triazol-3(2H)-one and 1,3,5-Triazine-2,4(3H)-dione Derivatives,”J. Med. Chem. (1992) vol. 35, pp. 189-194.
Janicki, P., et. al. “Analgesic Activity and Opiate Receptor Affinity of New Derivatives of 'N-Butylpiperidine,”Pol. J. Pharmacol. Pahrm. 1980, vol. 32, pp. 141-148.
Rylski, L., et. al. “Synteza Niektorych 1-[3-(Dwualkiloamino)-Propylo]-4-Acylo-4-Fenylopiperydyn,”Acta Polon. Pharm. 1970, No. 3, pp. 213-221.

Affiliated with

Also associated with

Rating

Pyrrolidinyl and piperidinyl ketone derivatives and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrolidinyl and piperidinyl ketone derivatives and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidinyl and piperidinyl ketone derivatives and uses... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4267988